Thompson Investment Management Inc. Has $594,000 Stake in Teleflex Incorporated (NYSE:TFX)

Thompson Investment Management Inc. raised its position in shares of Teleflex Incorporated (NYSE:TFX) by 31.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,340 shares of the medical technology company’s stock after acquiring an additional 800 shares during the period. Thompson Investment Management Inc.’s holdings in Teleflex were worth $594,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of the company. Janus Henderson Group PLC boosted its holdings in Teleflex by 2.8% during the third quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company’s stock valued at $1,329,704,000 after acquiring an additional 147,147 shares during the period. State Street Corp boosted its holdings in Teleflex by 1.0% during the third quarter. State Street Corp now owns 2,057,080 shares of the medical technology company’s stock valued at $508,757,000 after acquiring an additional 21,291 shares during the period. Geode Capital Management LLC boosted its holdings in Teleflex by 0.5% during the third quarter. Geode Capital Management LLC now owns 1,130,560 shares of the medical technology company’s stock valued at $278,676,000 after acquiring an additional 5,746 shares during the period. Massachusetts Financial Services Co. MA boosted its holdings in Teleflex by 0.4% during the third quarter. Massachusetts Financial Services Co. MA now owns 427,579 shares of the medical technology company’s stock valued at $105,749,000 after acquiring an additional 1,884 shares during the period. Finally, Point72 Asset Management L.P. boosted its holdings in Teleflex by 31.2% during the third quarter. Point72 Asset Management L.P. now owns 407,442 shares of the medical technology company’s stock valued at $100,768,000 after acquiring an additional 96,958 shares during the period. 95.62% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on the stock. StockNews.com upgraded shares of Teleflex from a “hold” rating to a “buy” rating in a report on Thursday, November 28th. Truist Financial reduced their target price on shares of Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a research note on Wednesday, December 18th. Mizuho reduced their target price on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research note on Friday, November 1st. Royal Bank of Canada reduced their target price on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research note on Friday, November 1st. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Teleflex in a research note on Monday, December 16th. Three equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, Teleflex has an average rating of “Moderate Buy” and an average target price of $252.50.

Teleflex Stock Performance

NYSE:TFX opened at $171.13 on Friday. Teleflex Incorporated has a 12-month low of $170.30 and a 12-month high of $256.85. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. The firm has a market capitalization of $7.95 billion, a PE ratio of 34.02, a price-to-earnings-growth ratio of 1.72 and a beta of 1.16. The firm has a 50-day moving average price of $180.04 and a 200 day moving average price of $211.25.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.